Made in Africa: What’s Driving Pharma Manufacturing

Based in Geneva, Switzerland, Daniel is an Engagement Manager in IQVIA’s EMEA Thought Leadership team. Daniel’s work focuses on exploring current and emerging trends within the realms of global health security, health system strengthening, and equity in access to life-saving commodities and services. Daniel has close to 20 years of experience in the multilateral sector, having occupied advisory positions in the United Nations system, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and a host of civil society organizations. His expertise covers areas such as and health policy, development operations, public-private partnerships and multi-stakeholder coordination. Daniel holds graduate degrees in public management and social policy and development from the Universidad Metropolitana in Caracas, Venezuela, and the University of Texas at Austin, respectively, with training in health policy and economics at the London School of Economics.

Pushpa Vijayaraghavan leads the healthcare advisory practice at Sathguru Management Consultants. Pushpa advises Governments on policy as well as leading companies on strategy and innovation access. Pushpa has been involved in shaping marque projects globally such as the National Biopharma Mission in India and vaccine manufacturing capacity development in Sub Saharan Africa.

Pushpa serves on the Governance Board of the Medicines Patent Pool, a UN founded body to enable access to medicines in LMIC. Pushpa has been an active member of the CII National Committee on Biotech and Pharmaceuticals, is on the BioNest funding committee of BIRAC, Department of Biotechnology, and was recognized as one of the twenty ‘Women Leaders in Healthcare’ in India in 2018 by Medgate Today.

As the Vaccine Manufacturing Lead at CEPI (Coalition for Epidemic Preparedness Innovations), Vishal plays a pivotal role in advancing global efforts to bolster epidemic and pandemic response preparedness, particularly in low- and middle-income countries (LMICs). With a steadfast commitment to supporting geo-diversification of vaccine manufacturing, Vishal spearheads initiatives aimed at enhancing the speed, scale, and accessibility of vaccines through innovation and technology transfer.

Vishal's strategic vision drives the establishment and maintenance of CEPI preferred partner vaccine manufacturing facilities, ensuring a robust infrastructure capable of meeting the evolving demands of public health crises. Through his leadership, Vishal empowers collaborations that strengthen global vaccine manufacturing capabilities, safeguarding communities worldwide against emerging infectious threats.

Rishabh has been part of Clinton Health Access since 2023, overseeing the vaccines market within the organisation. Founded in 2002, CHAI was set up with a goal in mind to help save the lives of millions of people living with HIV/AIDS. Today, they support government priorities across many areas, including other infectious diseases, non-communicable diseases, women's and children’s health, health workforce and financing, assistive technologies for disabilities, and the intersection of climate and health.